Browse by author
Lookup NU author(s): Professor Graham Jackson, Dr Anne Lennard, Dr Penelope Taylor, Dr Peter Carey, Dr Brian Angus, Dr Helen Lucraft, Professor Stephen Proctor, Dr Claire Bradford, Dr Rosalind Cartner, Dr Roger Finney, Dr David Goff
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
We report the safety and efficacy of autologous bone marrow transplantation (ABMT) in 30 patients with high-grade non-Hodgkin's lymphoma (NHL) in first complete remission (CR1) following remission induction chemotherapy. Two patients relapsed prior to ABMT. All patients were conditioned with high-dose melphalan. In addition, ten received fractionated total body irradiation, one hemi-body irradiation and four high-dose etoposide. Unmanipulated non-cryopreserved autologous marrow was reinfused within 56h of harvesting. Engraftment occurred in all patients with a median of 11 days of neutropenia (<0.5 x 10(9) 1(-1)), a median requirement for platelet transfusion of 3 days and packed red cell transfusion of 2 units, with a median hospital stay of 18 days post transplant. There was no procedure-related mortality and only minor morbidity was observed. Two patients relapsed at 1 and 2 months post transplantation, and one patient died of carcinoma of the lung 33 months after transplantation. The remaining 25 patients remain alive, well and in CR1 with a median follow-up of 44 months. The event-free survival at 3 years for all patients considered for ABMT was 83%. We conclude that ABMT for high-grade NHL in CR1 with noncryopreserved marrow results in rapid haematoiogical recovery without growth factor support. It is safe and is associated with high survival when used as consolidation of CR in high-risk patients.
Author(s): Jackson GH, Lennard AL, Taylor PRA, Carey P, Angus B, Lucraft HH, Evans RGB, Proctor SJ, Abela M, Bradford C, Browning N, Cartner R, Chandler J, Condie P, Dewar M, Finney R, Galloway M, Goff D, Hendrick A, et al
Publication type: Article
Publication status: Published
Journal: British Journal of Cancer
Year: 1994
Volume: 70
Issue: 3
Pages: 501-505
Print publication date: 01/09/1994
ISSN (print): 0007-0920
ISSN (electronic): 1532-1827
Publisher: Nature Publishing Group
URL: http://dx.doi.org/10.1038/bjc.1994.335
DOI: 10.1038/bjc.1994.335
Altmetrics provided by Altmetric